Phenotypic and Functional Lymphocyte Recovery After CD34 + -Enriched Versus Non-T Cell-Depleted Autologous Peripheral Blood Stem Cell Transplantation
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
To determine the effect of CD34+ selection on immune recovery after high-dose chemo/radiotherapy in the setting of autologous stem cell transplantation (ASCT), we analyzed quantitative and qualitative lymphocyte reconstitution for up to 1 year post-transplantation in 27 consecutive adult patients receiving either CD34+-enriched or unmanipulated autologous stem cell (SC) grafts. Pretransplant immunological parameters were identical for both treatment groups. Total lymphocyte counts as well as CD3+ T cells provided a similar course of recovery in both cohorts, returning to baseline values within the first 3 months. There were no significant differences in the reconstitution kinetics of CD4+, CD8+, CD45RA+, and CD45RO+ T cells. CD4+ and CD45RA+ T cells between the two groups were significantly decreased within the first 6 months, returning to pretransplant baseline values by 1 year. Although within the first 3 months the majority of CD3+ cells were activated as demonstrated by expression of HLA-DR, we observed a significant loss of CD25+ T cells in both groups within the first 6 months. B cell numbers returned to baseline values within 3 months but in vivo B cell function measured by serum immunoglobulin M (IgM) and IgA levels did not recover as early as 6 months post-transplantation. T cell function measured by proliferation in response to the lectins phytohemagglutinin (PHA) and Concanavalin A (ConA) and to alloantigens in the mixed lymphocyte reaction (MLR) was significantly impaired, but tended to return to pretransplant baseline values by 1 year. Although preliminary, our results provide strong evidence that T cell depletion (TCD) by CD34+ enrichment using the CellPro device does not result in delayed phenotypic immune reconstitution after autologous peripheral blood stem cell transplantation (PB-SCT). Even in the absence of a high thymic T cell regenerative capacity in adults, T cell numbers and subset distributions were restored within the time frame studied. T and B cell function, however, remained significantly impaired for a prolonged period of time (>6 months after SCT) with a more profound defect in patients autografted with CD34+-enriched SC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a product that is enriched with CD34+ cells, CTX001 may have contributed to the delay in lymphocyte recovery, similar to what has been observed after T-cell-depleted transplantation.33,34”
From CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia (2021) · cites this paper as [34]
Citations
Cites
Goycoolea, A. (1997) · Cited by 3,615
Ford, R., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,720
GOLDMAN, J. M., GALE, R. P., HOROWITZ, M. M., BIGGS, J. C., CHAMPLIN, R. E., GLUCKMAN, E., HOFFMANN, R. G., JACOBSEN, S. J., MARMONT, A. M., McGLAVE, P. B., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-6-806 · Cited by 838
T-cell depletion of HLA-identical transplants in leukemia
Marmont, A., Horowitz, M., Gale, R., Sobocinski, K., Ash, R., van Bekkum, D., Champlin, R., Dicke, K., Goldman, J., & Good, R. (1991) · Blood · doi:10.1182/blood.v78.8.2120.2120 · Cited by 745
Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., & Weaver, C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.10.2547 · Cited by 635
Shpall, E. J., Jones, R. B., Bearman, S. I., Franklin, W. A., Archer, P. G., Curiel, T., Bitter, M., Claman, H. N., Stemmer, S. M., & Purdy, M. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.28 · Cited by 375
Ottinger, H., Beelen, D., Scheulen, B., Schaefer, U., & Grosse-Wilde, H. (1996) · Blood · doi:10.1182/blood.v88.7.2775.bloodjournal8872775 · Cited by 351
Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Guillaume, T., Rubinstein, D. B., & Symann, M. (1998) · Blood · doi:10.1182/blood.v92.5.1471 · Cited by 323
Mackall, C., Granger, L., Sheard, M., Cepeda, R., & Gress, R. (1993) · Blood · doi:10.1182/blood.v82.8.2585.2585 · Cited by 292
Keever, C., Small, T., Flomenberg, N., Heller, G., Pekle, K., Black, P., Pecora, A., Gillio, A., Kernan, N., & O'Reilly, R. (1989) · Blood · doi:10.1182/blood.v73.5.1340.1340 · Cited by 247
Research works printed but not linked: 5
- Dreger P, 1995, Exp Hematol, 23, 147
- Ashihara E, 1994, Bone Marrow Transplant, 13, 377
- Gaschet J, 1995, Bone Marrow Transplant, 16, 427
- Vescio R, 1999, Blood, 93, 1858
- Rutella S, 1998, Exp Hematol, 26, 1024
Cited by
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., Foell, J., de la Fuente, J., Grupp, S., Handgretinger, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2031054 · Cited by 1,962
Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis
Cox, A. L., Thompson, S. A. J., Jones, J. L., Robertson, V. H., Hale, G., Waldmann, H., Compston, D. A. S., & Coles, A. J. (2005) · European Journal of Immunology · doi:10.1002/eji.200535075 · Cited by 291
Goldberg, S. L., Pecora, A. L., Alter, R. S., Kroll, M. S., Rowley, S. D., Waintraub, S. E., Imrit, K., & Preti, R. A. (2002) · Blood · doi:10.1182/blood.v99.4.1486 · Cited by 190
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis
Ponchel, F., Morgan, A. W., Bingham, S. J., Quinn, M., Buch, M., Verburg, R. J., Henwood, J., Douglas, S. H., Masurel, A., Conaghan, P., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0671 · Cited by 165
García‐Suárez, J., de Miguel, D., Krsnik, I., Bañas, H., Arribas, I., & Burgaleta, C. (2005) · American Journal of Hematology · doi:10.1002/ajh.20492 · Cited by 118
Carreras, E., Saiz, A., Marín, P., Martínez, C., Rovira, M., Villamor, N., Aymerich, M., Lozano, M., Fernández‐Avilés, F., Urbano-Izpizua, Á., et al. (2003) · PubMed · Cited by 124
Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia
Ponchel, F., Verburg, R. J., Bingham, S. J., Brown, A. K., Moore, J. J., Protheroe, A. S., Short, K., Lawson, C. A., Morgan, A. W., Quinn, M. A., et al. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1452 · Cited by 109
Bou‐Fakhredin, R., Franceschi, L. D., Motta, I., Cappellini, M. D., & Taher, A. T. (2022) · Pharmaceuticals · doi:10.3390/ph15060753 · Cited by 65
D’Souza, A., Wilson, J. D., Mukherjee, S., & Jaiyesimi, I. A. (2010) · Clinical Lymphoma Myeloma & Leukemia · doi:10.3816/clml.2010.n.009 · Cited by 50
Steurer, M., Clausen, J., Gotwald, T. F., Gunsilius, E., Stockhammer, G., Gastl, G. A., & Nachbaur, D. (2003) · Transplantation · doi:10.1097/01.tp.0000078897.11633.5f · Cited by 48
Self-citationLenalidomide enhances myeloma-specific T-cell responsesin vivoandin vitro
Krämer, I., Engelhardt, M., Fichtner, S., Neuber, B., Medenhoff, S., Bertsch, U., Hillengaß, J., Raab, M. S., Hose, D., Ho, A. D., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1139662 · Cited by 40
Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy
Talmadge, J. E. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00014-6 · Cited by 41
Reimer, P., Kunzmann, V., Wilhelm, M., Weißbrich, B., Kraemer, D. M., Berghammer, H., & Weißinger, F. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0630-4 · Cited by 29
van Heeckeren, W. J., Vollweiler, J., Fu, P., Cooper, B., Meyerson, H. J., Lazarus, H. M., Simic, A., Laughlin, M. J., Gerson, S. L., & Koç, O. N. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05827.x · Cited by 28
Infections after CD34‐selected or unmanipulated autologous hematopoietic stem cell transplantation
Frère, P., Pereira, M., Fillet, G., & Beguin, Y. P. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00569.x · Cited by 26
Damiani, D., Stocchi, R., Masolini, P., Michelutti, A., Geromin, A., Sperotto, A. A., Skert, C., Michieli, M., Baccarani, M., & Fanin, R. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg107 · Cited by 24
Boekhorst, P. A. W. T., Lamers, C. H. J., Schipperus, M. R., Hintzen, R. Q., van der Holt, B., Cornelissen, J. J., Löwenberg, B., & Gratama, J. W. (2006) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705333 · Cited by 19
Neuro-endocrine-immune Crosstalk and Implications for Cancer Therapy
Dronca, R. S., Markovic, S. N., & Holtan, S. G. (2011) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000102e · Cited by 20
Gamage, U., Warnakulasuriya, K., Hansika, S., & Silva, G. N. (2023) · Thalassemia Reports · doi:10.3390/thalassrep13010006 · Cited by 20
van der Velden, A. M. T., Claessen, A. M. E., van Velzen‐Blad, H., Biesma, D. H., & Rijkers, G. T. (2007) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705706 · Cited by 15
Rutella, S., Pierelli, L., Sica, S., Rumi, C., & Leone, G. G. M. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097745 · Cited by 13
Seidel, M. G., Fritsch, G., Matthes‐Martin, S., Lawitschka, Á., Lion, T., Pötschger, U., Rosenmayr, A., Fischer, G., Gadner, H., & Peters, C. (2005) · PubMed · Cited by 12
Endo, T., Sato, N., Koizumi, K., Nishio, M., Fujimoto, K., Yamamoto, S., Sakai, T., Bohgaki, T., Sawada, K., & Koike, T. (2004) · Cytotherapy · doi:10.1080/14653240410004907 · Cited by 5
Singh, R. K., Varney, M. L., Leutzinger, C., Vose, J. M., Bierman, P. J., Buyukberber, S., Ino, K., Loh, K. K., Nichols, C. R., Inwards, D. J., et al. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.03.006 · Cited by 4
Immune Recovery Following Allogeneic Blood Transplantation
Talmadge, J. E. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-333-0_15
with rheumatoid arthritis Dysregulated lymphocyte proliferation and differentiation in patients
Markham, A. F., Emery, P., van Laar, J. M., Isaacs, J. D., Henwood, J., Douglas, S., Masurel, A., Conaghan, P. G., Gesinde, M., Taylor, J., et al. (2013)
van Heeckeren, W. J., Fu, P., Meyerson, H. J., Simic, A., Gerson, S. L., & Koç, O. N. (2005)
Schlenke, P., Sheikhzadeh, S., & Kirchner, H. (2002) · Journal of Laboratory Medicine · doi:10.1515/labmed.2002.047
Analyse des fonctions lymphocytaires
(2014) · Elsevier eBooks · doi:10.1016/b978-2-294-74025-1.00014-0
Enfoque terapéutico de la anemia falciforme
Soto-Manzano, A. V., Córdoba-García, S., Castaño, L. M. F., Uribe-Ramírez, M., & Sánchez, L. M. M. (2025) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1553
Metadata
- Authors
- Nachbaur, D., Kropshofer, G., Heitger, A., Lätzer, K., Glassl, H., Ludescher, C., Nussbaumer, W., & Niederwieser, D.
- Affiliations
- Innsbruck Medical University (AT)
- University Hospital Innsbruck (AT)
- University Hospital Leipzig (DE)
- Venue
- Journal of Hematotherapy & Stem Cell Research
- Publisher
- SAGE Publications
- Published
- 2000-10
- Volume
- 9
- Issue
- 5
- Pages
- 727-736
- ISSN
- 1525-8165 (ISSN-L)
- OpenAlex
- W2172655914
- Cited by
- 30
- References
- 37
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Stem Cells and Development (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- autologous peripheral blood stem cell transplantation, CD34+ cell selection, T cell depletion, immune reconstitution, lymphocyte recovery, T cell subsets, B cell function, T cell function, CD4+ T cells, CD45RA+ T cells, CD25+ T cells, HLA-DR expression, serum immunoglobulins, mixed lymphocyte reaction
- MeSH terms
- Adult, B-Lymphocytes, Cells, Cultured, Female, Follow-Up Studies, HLA-DR Antigens, Humans, Kinetics, Lymphocyte Depletion, Lymphocyte Activation, Male, Middle Aged, Neoplasms, T-Lymphocytes, Transplantation, Autologous, Antigens, CD, Immunophenotyping, Hematopoietic Stem Cell Transplantation, Antigens, CD34
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.